Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline - Genetic Engineering & Biotechnology News

Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline  Genetic Engineering & Biotechnology News

Merck & Co. said today it has agreed to acquire Immune Design for approximately $300 million, in a deal designed to boost the buyer's vaccine pipeline and ...